e-learning
resources
London 2016
Tuesday, 06.09.2016
New insights into pulmonary rehabilitation for chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA)
Olena Krakhmalova (Kharkiv, Ukraine), Olena Krakhmalova, Yulia Kharchenko, Olena Izmailova
Source:
International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Session:
New insights into pulmonary rehabilitation for chronic lung diseases
Session type:
Poster Discussion
Number:
3588
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Olena Krakhmalova (Kharkiv, Ukraine), Olena Krakhmalova, Yulia Kharchenko, Olena Izmailova. The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA). Eur Respir J 2016; 48: Suppl. 60, 3588
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prevalence and characteristics of patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD): “overlap syndrome (OS)”
Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea
Year: 2020
Long term effects of PAP therapy on patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) (overlap syndrome)
Source: Sleep and Breathing Conference 2021
Year: 2021
Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
The relationship between the severity of obstructive sleep apnea syndrome and severity of chronic obstructive pulmonary disease (COPD) associated with coronary artery disease (CAD)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Cardiohemodynamics parameters in patients with COPD and obstructive sleep apnea, (OSA).
Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Year: 2017
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
Chronic respiratory failure in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Smoking (active and former) among factors influencing severity of both pathologies in a population with obstructive sleep apnea (OSA) and chronic obstructive bronhopneumopathy (COPD)
Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies
Year: 2010
Prevalence of stroke in obstructive sleep apnoea (OSA) patients
Source: Eur Respir J 2007; 30: Suppl. 51, 331s
Year: 2007
What causes morning tiredness in COPD patients?
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 97s
Year: 2003
Prevalence of overlap syndrome and its correlation with severity of obstructive sleep apnea syndrome
Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults
Year: 2015
The clinical significance nocturnal hypoventilation (NH) in patients with severe obstructive sleep apnoea (OSA)
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020
CPAP therapy in idiopathic pulmonary fibrosis (IPF) patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
The prevalence of obstructive sleep apnea (OSA) in patients with severe asthma and the association between severity of OSA and asthma control
Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases
Year: 2020
The symptom prevalence of obstructive sleep apnea syndrome in patients with asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 198s
Year: 2006
Prevalence of cardiorespiratory disease increase with increasing severity of obstructive sleep apnoea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 322s
Year: 2002
Asthma control in patients with asthma / obstructive sleep apnea overlap syndrome
Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept